Paracetamol vs Ibuprofen for PDA Closure in Preterm Infants.

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is suspended. It plans to enroll 120 participants.

Also called NCT02056223

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2/3
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02056223
  • EudraCT 2013-004955-19
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Italy (from the registry)
Registry status
  • Suspended (from the registry)

Technical summary

Registry record NCT02056223. Randomized; quadruple masking; primary purpose treatment. Start 2017-01-09 (actual); primary completion 2019-10-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Paracetamol vs Ibuprofen for PDA Closure in Preterm Infants.
Acronym
PARIDA
Condition
Ductus Arteriosus Patent
Condition
Respiratory Distress Syndrome
Intervention (Drug)
Intravenous paracetamol
Intervention (Drug)
Intravenous ibuprofen
Lead sponsor
University of Padova (class: other)

Record details

Record id
cardio:ct-nct02056223
Content hash
eb00c19f1b15ceaecf475be190c812bd60d80a95681a42c91a8e2cf0895c661a